Position in SHC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,823,216
+$1,416,756 QoQ
Shares Held
127,142
+451.8% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SHC Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Brevan Howard Capital Management LP holds $32,347,391 across 20 Diagnostics & Research names. SHC ranks #7 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
30,881 | $6,175,891 | |
| 2 | QGEN |
Qiagen N.V.
|
133,177 | $5,332,407 | |
| 3 | DHR |
Danaher Corp /De/
|
21,586 | $4,092,705 | |
| 4 | A |
Agilent Technologies, Inc.
|
35,679 | $4,066,692 | |
| 5 | ADPT |
Adaptive Biotechnologies Corp
|
170,928 | $2,372,480 | |
| 6 | RVTY |
Revvity, Inc.
|
26,071 | $2,284,080 | |
| 7 | SHC |
Sotera Health Co
This page
|
127,142 | $1,823,216 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
7,723 | $1,317,080 |
All Filings in SHC
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,823,216 | 127,142 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $406,460 | 23,042 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $512,373 | 32,573 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $669,668 | 60,222 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $365,283 | 31,328 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,082,853 | 79,156 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $582,429 | 34,876 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||